• BicD and MAP7 Synergistically Activate Drosophila Kinesin-1

  2026-04-25

  This study elucidates how Drosophila BicD and MAP7 coordinately relieve auto-inhibition and enhance processivity of homodimeric kinesin-1 motors. These findings provide mechanistic insight into adaptor-motor regulation, advancing our understanding of intracellular transport and offering a foundation for experimental designs that interrogate motor activity modulation.

• Vorinostat (SAHA): Precision HDAC Inhibition for Epigenetic

  2026-04-24

  Explore how Vorinostat (suberoylanilide hydroxamic acid) uniquely empowers epigenetic modulation in oncology. This article provides a deep dive into its mechanism, advanced workflows, and practical assay insights beyond standard protocols.

• CUDC-907: Dual PI3K and HDAC Inhibitor for Cell-Based Assays

  2026-04-24

  CUDC-907 addresses the need for precise dual inhibition of both PI3K and HDAC signaling in cancer research, enabling targeted study of cell cycle and apoptotic pathways in vitro. It is best suited for controlled laboratory applications using established cell models and should not be applied in diagnostic or clinical contexts.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Practical Use Guide

  2026-04-23

  The FITC Goat Anti-Mouse IgG (H+L) Antibody provides a reliable, affinity-purified solution for fluorescent detection of mouse IgG in immunofluorescence and flow cytometry workflows. It should be used where high specificity and signal amplification are needed, but is not suitable for non-mouse IgG detection or applications outside the fluorescence-based immunoassay context.

• Applied Workflows with the DiscoveryProbe Metabolism-related

  2026-04-23

  The DiscoveryProbe™ Metabolism-related Compound Library empowers researchers to interrogate metabolic pathways with a rigorously validated, cell-permeable compound set. This guide provides stepwise protocol enhancements, troubleshooting strategies, and cross-domain insights—enabling advanced applications from metabolic enzyme inhibition to antiviral pathway discovery.

• Prochlorperazine: Dopamine D2 Antagonist for Translational R

  2026-04-22

  Prochlorperazine stands out as a versatile dopamine D2 receptor antagonist, bridging antiemetic therapy and advanced melanoma and antiviral research. Explore robust workflows, troubleshooting strategies, and practical protocol enhancements that ensure reproducibility and insight for preclinical and translational studies.

• Radiopathomics Signature Predicts Immunotherapy Response in

  2026-04-22

  This study introduces a radiopathomics signature (RPS) that integrates CT and digital pathology data, using interpretable machine learning to predict response to immunotherapy-based combination therapy in gastric cancer. The RPS demonstrates superior predictive accuracy over established biomarkers and provides new insights into immune-related mechanisms of treatment response.

• BMS-345541: Precision IKK-1/IKK-2 Inhibition for Inflammatio

  2026-04-21

  BMS-345541 (free base) is a highly selective IKK-1/IKK-2 inhibitor that empowers researchers to dissect NF-κB signaling in inflammation and cancer models with robust, reproducible outcomes. This article guides you through optimized workflows, data-driven parameter selection, and troubleshooting strategies informed by both published literature and real-world applications.

• Atorvastatin-Induced Ferroptosis Signature in Hepatocellular

  2026-04-21

  This study establishes a four-gene ferroptosis-related prognostic signature for hepatocellular carcinoma (HCC) and experimentally demonstrates that atorvastatin induces ferroptosis to inhibit HCC cell growth and migration. The findings highlight a novel therapeutic avenue for HCC by leveraging a well-characterized HMG-CoA reductase inhibitor.

• Co-Targeting BCL-xL and MCL-1 Disrupts Apoptosis in Mesothel

  2026-04-20

  This study demonstrates that simultaneous inhibition of BCL-xL and MCL-1 in diffuse mesothelioma models induces acute mitochondrial dysfunction and synthetic lethality, revealing the risks of dual targeting in this context. Importantly, selective MCL-1 inhibition lowered apoptotic thresholds and enhanced chemosensitivity without excessive toxicity, offering a safer therapeutic strategy.

• Jasplakinolide: Advanced Actin Polymerization Inducer for Pr

  2026-04-20

  Explore Jasplakinolide's unique role as a potent actin polymerization inducer, with deep technical insights into its mechanisms, assay optimization, and cross-domain research value. This article delivers a distinctive analysis for cell biologists and assay developers.

• Translational Precision: HyperScript™ cDNA Synthesis Redefin

  2026-04-19

  This thought-leadership article explores the mechanistic advances and strategic impact of the HyperScript™ First-Strand cDNA Synthesis Kit for translational researchers tackling gene expression analysis. Integrating insights from recent regulatory genomics, experimental benchmarking, and workflow optimization, we dissect how enhanced reverse transcriptase design and innovative primer strategies enable reliable cDNA synthesis—even from challenging RNA templates. By bridging molecular biology with translational application, this piece offers actionable guidance for researchers seeking to unlock low copy gene detection, robust qPCR, and precision medicine advances.

• Optimizing Cancer Research with PP 1 Src Family Tyrosine Kin

  2026-04-18

  PP 1 (Src family tyrosine kinase inhibitor) empowers researchers to dissect complex oncogenic and immune signaling pathways with unmatched selectivity and potency. This guide delivers actionable protocols, cross-disciplinary applications, and troubleshooting insights—ensuring robust, reproducible results in cancer biology and immunology experiments.

• Pregnenolone Carbonitrile: New Frontiers in Water Homeostasi

  2026-04-17

  Explore how Pregnenolone Carbonitrile, a key PXR agonist, reveals novel regulatory roles in water homeostasis alongside its established applications in hepatic detoxification. This article offers a deeper, cross-system perspective not found in standard guides.

• SERCA Inhibition by BHQ Enhances HSC Mobilization via ER Str

  2026-04-16

  Li et al. (2025) demonstrate that selective inhibition of SERCA by 2,5-di-tert-butylbenzene-1,4-diol (BHQ) induces ER stress, facilitating hematopoietic stem cell (HSC) mobilization through the CaMKII-STAT3-CXCR4 pathway. This finding provides a mechanistic framework for leveraging mild ER stress to improve HSC collection strategies in transplantation settings.

14775 records 1/985 page Next 12345 下5页 Last page